Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway
Jian Zhou(The First People's Hospital of Guiyang), Chunxue Bai(Fudan University)
Cited by 41
Related Papers
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.7k
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
|The Lancet|2019|759
Bone marrow‐derived mesenchymal stem cells enhance autophagy <i>via </i><scp>PI</scp>3K/<scp>AKT</scp> signalling to reduce the severity of ischaemia/reperfusion‐induced lung injury
|Journal of Cellular and Molecular Medicine|2015|64
PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway
|Cellular Physiology and Biochemistry|2018|51
Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China Pulmonary Health Study
|The Lancet Regional Health - Western Pacific|2024|45